Exelixis Investor Relations Material
Latest events
Q1 2024
Exelixis
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Exelixis Inc
Access all reports
Exelixis, Inc., is a US-based biotechnology company within oncology. The company focuses on the discovery, development, and commercialization of new medicines to treat cancers in the U.S. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its products also comprise MINNEBRO tablets for the treatment of genetic conditions.
Key slides for Exelixis Inc
Q2 2023
Exelixis Inc
Q1 2024
Exelixis Inc
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
EXEL
Country
🇺🇸 United States